ID: ALA4593432

Max Phase: Preclinical

Molecular Formula: C13H19N3S

Molecular Weight: 249.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCC/C(=N\NC(N)=S)c1ccccc1

Standard InChI:  InChI=1S/C13H19N3S/c1-2-3-5-10-12(15-16-13(14)17)11-8-6-4-7-9-11/h4,6-9H,2-3,5,10H2,1H3,(H3,14,16,17)/b15-12+

Standard InChI Key:  JDUCHZITNJKBHX-NTCAYCPXSA-N

Associated Targets(non-human)

Tyrosinase 438 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.38Molecular Weight (Monoisotopic): 249.1300AlogP: 2.80#Rotatable Bonds: 6
Polar Surface Area: 50.41Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.67CX Basic pKa: 2.69CX LogP: 3.54CX LogD: 3.54
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.35Np Likeness Score: -1.14

References

1. Hałdys K, Latajka R..  (2019)  Thiosemicarbazones with tyrosinase inhibitory activity.,  10  (3): [PMID:31015905] [10.1039/C9MD00005D]

Source